Stock screenerAll disclosures →
EDGAR →
NRIX
Conviction 80HealthcareScan · Mon, Aug 10, 2026NRIX$25.87+1.33%
ResistanceSupportVol 14Insider sell2
2
Vol MA14 1.07M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price25.87
Change+1.33%
Gap-0.74%
Rel volume0.96×
Avg volume1.08M
Avg $ vol25.69M
SMA 2023.88
SMA 5021.30
SMA 20017.54
Price vs 50+21.44%
Price vs 200+47.52%
MA stackbullish
50/200 cross—
Supertrendup · 22.38
RSI (14)71
MACD hist0.07
MACD crossbull · 1d
Stoch %K / %D95 / 92
ADX (14)24
+DI / −DI27 / 14
RSI divergenceBearish
MACD divergenceBullish
ATR %+4.30%
ADR %4.44%
52w high25.87
52w low8.24
From 52w high+0.00%
Above 52w low+213.96%
New 52w highYes
SqueezeFired
Bollinger width14.95%
%B1.06
Donchian pos95.53%
Donchian high26.03
Donchian low22.45
AVWAP (52w high)25.69
vs AVWAP high+0.71%
AVWAP (52w low)16.80
vs AVWAP low+54.01%
OBV trendUp
Chaikin MF (20)0.14
Today vs 20d0.96×
Avg vol (14d)1.07M
Avg vol (20d)1.08M
Avg $ vol (20d)25.69M
Market cap2.68B
RS 3m (vs SPY)+51.12%
RS 6m (vs SPY)+45.95%
RS line new highYes
Trend template8/8
Technical rank92.0
1 week+11.41%
1 month+12.19%
3 months+56.60%
6 months+53.53%
1 year+156.90%
YTD+43.24%
P/E-10.15
P/B6.67
P/S31.97
P/FCF-10.19
EPS-3.05
Div yield—
ROE-65.68%
ROA-49.38%
Debt/Eq—
Current6.34
EV/EBITDA-9.45
Gross margin—
Net margin-314.90%
Rev growth53.95%
EPS growth-36.62%
Price target34.31
Target upside32.62%
Analyst ratingBuy
Institutional116.32%
Ent. value2.62B
Revenue9.04M
Net income-89.53M
Gross profit—
Free cash flow-263.47M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out103.41M
Employees357
ListedFri, Jul 24, 2020
Free float97.8M
Float %94.6%
Short interest17.98M
Days to cover13.9d
Short volume36.3%
Squeeze score62 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.81 vs −$0.73
Last surprise-11.0% miss
Setup gradeA
Conviction80 / 100
Pattern quality—
Tech rank92.0 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance24.98
Support18.87
Days since event—
Candle confirm—
News sentiment—
Financials as of Sun, May 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in NRIX
No recent disclosed trades by Congress in NRIX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in NRIX · 3 buys · 7 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Hansen Gwenn Chief Scientific Officer · Common Stock · 2026-08-05 | Sell | 4.36K | $109K | 2026-08-05 | 2026-08-05 |
Hansen Gwenn Chief Scientific Officer · Employee Stock Option (right to buy) · 2026-08-05 | Exercise | 4.36K | — | 2026-08-05 | 2026-08-05 |
Hansen Gwenn Chief Scientific Officer · Common Stock · 2026-08-05 | Exercise | 4.36K | $8K | 2026-08-05 | 2026-08-05 |
Hansen Gwenn Chief Scientific Officer · Common Stock · 2026-08-04 | Sell | 1.5K | $36K | 2026-08-04 | 2026-08-05 |
Hansen Gwenn Chief Scientific Officer · Common Stock · 2026-08-04 | Sell | 2.61K | $64K | 2026-08-04 | 2026-08-05 |
Ring Christine Chief Legal Officer · Employee Stock Option (right to buy) · 2026-06-25 | Exercise | 13.33K | — | 2026-06-25 | 2026-06-25 |
Ring Christine Chief Legal Officer · Employee Stock Option (right to buy) · 2026-06-25 | Exercise | 15.6K | — | 2026-06-25 | 2026-06-25 |
Hansen Gwenn Chief Scientific Officer · Common Stock · 2026-06-25 | Sell | 5.39K | $108K | 2026-06-25 | 2026-06-25 |
Ring Christine Chief Legal Officer · Common Stock · 2026-06-25 | Exercise | 13.33K | $97K | 2026-06-25 | 2026-06-25 |
Ring Christine Chief Legal Officer · Common Stock · 2026-06-25 | Exercise | 15.6K | $136K | 2026-06-25 | 2026-06-25 |
SEC filings
EDGAR filings in NRIX · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.